Iluvien: payments to doctors
Payments that named Iluvien as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.4M
- Providers
- 3,452
- Transactions
- 19,131
- Average per transaction
- $177
The per-transaction average — $177 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,452 providers the average total is $982, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Alimera Sciences, Inc. | $3,256,115 | 96.0% |
| ANI Pharmaceuticals, Inc. | $135,451 | 4.0% |